Recanaclotide
- Generic Name
- Recanaclotide
- Drug Type
- Biotech
- CAS Number
- 1667762-62-0
- Unique Ingredient Identifier
- 9QBH807006
- Background
Recanaclotide is under investigation in clinical trial NCT01712412 (Phase 2a Study of IW-9179 to Treat Functional Dyspepsia).
Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)
- First Posted Date
- 2014-11-13
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT02289846
- Locations
- 🇺🇸
Ironwood Investigational Site, Ogden, Utah, United States
Phase 2a Study of IW-9179 to Treat Functional Dyspepsia
Phase 2
Terminated
- Conditions
- DyspepsiaFunctional Gastrointestinal Disorders
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2014-03-19
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT01712412
- Locations
- 🇳🇱
Andromed Leiden, Leiden, Netherlands
🇳🇱PreCare Trial and Recruitment, Beek, Netherlands
🇧🇪AZ Sint-Lucas Brugge, Brugge, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath